17 Nov 08 Bone Marrow Toxicity In Advanced Lung Cancer May Be Reduced By Proton Therapy And Concurrent Chemotherapy
Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, according to researchers from The University of Texas M. D. Anderson Cancer Center.
(more…)
Tags: Anderson Cancer Center, Bone Cancer, Bone Marrow Toxicity, Cancer Chemotherapy, Cancer Therapy, Cell Lung Cancer, Chemotherapy, Chemotherapy Patients, Imrt, Instances, Intensity Modulated Radiation, Lung Cancer, M D Anderson, M D Anderson Cancer Center, Non Small Cell Lung Cancer, Proton Beam Therapy, Proton Therapy, Small Cell Lung Cancer, University Of Texas, University Of Texas M D Anderson Cancer Center
07 Oct 08 Alternatives For Radiation Of Low-Grade Brain Tumors Found By Pediatric Study
A multi-institutional study led by researchers at The University of Texas M. D. Anderson Cancer Center has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can be effective in treating pediatric patients with unresectable or progressive low-grade glioma. The study was presented at the 40th annual International Society of Pediatric Oncology Meeting in Berlin, Germany. Low-grade glioma is the most common brain tumor in children.
(more…)
Tags: Anderson Cancer Center, Berlin Germany, Brain Tumor, Brain Tumors, Cancer Chemotherapy, Chemotherapy, Institutional Study, Led, Low Grade Glioma, M D Anderson, M D Anderson Cancer Center, Meeting In Berlin, Oncology, Pediatric Oncology, Pediatric Patients, Pediatric Study, Progressive, Radiation, University Of Texas, University Of Texas M D Anderson Cancer Center
04 Oct 08 Grants Will Fund 11 Translational Breast Cancer Research Studies
The University of Texas M. D. Anderson Cancer Center has received nearly $19 million in grants from Susan G. Komen for the Cure® as part of that organization’s new initiative to fast-track promising research to benefit breast cancer patients. Ranging from $120,000 to $7.5 million, the grants will be allocated across 11 different translational breast cancer research studies with the intent to bring treatments from the laboratory to patient care as quickly as possible.
(more…)
Tags: 5 Million, Anderson Cancer Center, Breast Cancer, Breast Cancer Patients, Breast Cancer Research, Cancer Research Studies, Fast Track, Grants, Initiative, Komen For The Cure, M D Anderson, M D Anderson Cancer Center, Patient Care, Promising Research, Susan G Komen, Susan G Komen For The Cure, Translational, University Of Texas, University Of Texas M D Anderson Cancer Center
04 Oct 08 5-Year, $52.7 Million Award Supports Broad Array Of Cancer Research
The National Cancer Institute (NCI) has renewed The University of Texas M. D. Anderson Cancer Center’s Cancer Center Support Grant, an essential step in extending the institution’s elite status as a comprehensive cancer center. In the process, M. D. Anderson was awarded NCI’s highest rating of “outstanding” during an intensive peer-review evaluation. The five-year renewal totals $52.
(more…)
Tags: Anderson Cancer Center, Array, Cancer Research, Cancer Support, Comprehensive Cancer Center, Elite Status, M D Anderson, M D Anderson Cancer Center, National Cancer Institute, Nci, Peer Review, University Of Texas, University Of Texas M D Anderson Cancer Center
04 Oct 08 5-Year, $52.7 Million Award Supports Broad Array Of Cancer Research
The National Cancer Institute (NCI) has renewed The University of Texas M. D. Anderson Cancer Center’s Cancer Center Support Grant, an essential step in extending the institution’s elite status as a comprehensive cancer center. In the process, M. D. Anderson was awarded NCI’s highest rating of “outstanding” during an intensive peer-review evaluation. The five-year renewal totals $52.
(more…)
Tags: Anderson Cancer Center, Array, Cancer Research, Cancer Support, Comprehensive Cancer Center, Elite Status, M D Anderson, M D Anderson Cancer Center, National Cancer Institute, Nci, Peer Review, University Of Texas, University Of Texas M D Anderson Cancer Center
30 Sep 08 Risk For Pancreatic Cancer May Be Increased By Hepatitis B Exposure
In a first-of-its-kind finding, researchers at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreatic cancer. The study, published in the Oct. 1 edition of the Journal of Clinical Oncology, also suggests that patients with this lethal form of cancer treated with chemotherapy may face danger of reactivation of their HBV.
(more…)
Tags: Anderson Cancer Center, Cancer Chemotherapy, Chemotherapy, Face, Hbv, Hepatitis, Hepatitis B, Hepatitis B Virus, Hepatitis Virus, Journal Of Clinical Oncology, M D Anderson, M D Anderson Cancer Center, Oncology, Pancreatic Cancer, Reactivation, Risk, University Of Texas, University Of Texas M D Anderson Cancer Center
25 Sep 08 Cancer Patients Who Receive Neoadjuvant Therapy Followed By Mastectomy May Not Need Radiation
Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy (RT) when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from The University of Texas M. D. Anderson Cancer Center. The findings were reported at the 50th Annual meeting of the American Society for Therapeutic Radiology and Oncology.
(more…)
Tags: Anderson Cancer Center, Annual Meeting, Breast Cancer, Breast Cancer Patients, Cancer Therapy, Chemotherapy, Limited, Lymph Node Involvement, M D Anderson, M D Anderson Cancer Center, Mastectomy, Oncology, Radiation Therapy, Rt, Stage Breast Cancer, Therapeutic Radiology, University Of Texas, University Of Texas M D Anderson Cancer Center
24 Sep 08 Amplified Gene In Cells Found In Urine Reveals Presence Bladder Cancer
Counting the copies of a specific gene in cells gathered from a urine sample may provide a simple, noninvasive way to detect bladder cancer, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports in the Journal of the National Cancer Institute. When the telltale gene, Aurora kinase A, is numerous and overexpressed in urothelial cells, errors during cell division follow, the team also found.
(more…)
Tags: Anderson Cancer Center, Aurora Kinase, Bladder Cancer, Cancer Journal, Cells, Journal Of The National Cancer Institute, Led, M D Anderson, M D Anderson Cancer Center, National Cancer Institute, Presence, University Of Texas, University Of Texas M D Anderson Cancer Center, Urine Sample
23 Sep 08 Whole Brain Radiation Increases Risk Of Learning And Memory Problems In Cancer Patients With Brain Metastases
Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to new research from The University of Texas M. D. Anderson Cancer Center.
(more…)
Tags: Anderson Cancer Center, Brain Cancer, Brain Learning, Brain Radiation, Brain Tumors, Cancer Patients, Learning And Memory, M D Anderson, M D Anderson Cancer Center, Memory Brain, Memory Problems, Metastases, Metastatic Brain Tumors, Radiation Therapy, Risk, Srs, University Of Texas, University Of Texas M D Anderson Cancer Center, Wbrt, Whole Brain
16 Sep 08 Advalytix Announces Study Of Single Circulating Tumor Cells With The M. D. Anderson Cancer Center
The Advalytix product team of Olympus is initiating a collaborative study with The University of Texas M. D. Anderson Cancer Center to characterize circulating tumor cells in breast cancer patients. The study combines Advalytix’s sensitive AmpliGrid molecular analysis platform, multiplex primer design, and integrated
(more…)
Tags: Analysis Platform, Anderson Cancer Center, Breast Cancer, Breast Cancer Patients, Circulating Tumor Cells, Collaborative Study, M D Anderson, M D Anderson Cancer Center, Olympus, University Of Texas, University Of Texas M D Anderson Cancer Center
16 Sep 08 Lung Cancer Risk Models Created For Specific Populations, Prediction Refined
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research. In the first study to focus on African-Americans, researchers found unique results based on increased exposure to certain risks.
(more…)
Tags: African Americans, Anderson Cancer Center, Cancer Prevention Research, Cancer Research, Dna Repair, Epidemiologists, Lung Cancer, Lung Cancer Risk, M D Anderson, M D Anderson Cancer Center, Populations, Prediction Models, Risk Factors, Risk Models, Risk Prediction, September Issue, University Of Texas, University Of Texas M D Anderson Cancer Center
